(Alliance News) - Olidata Spa announced Wednesday that it has embarked on a collaboration with the Fondazione Policlinico Universitario Campus Bio-Medico to develop technology for early diagnosis and screening of lung cancer.

The Ailanton project was implemented through an integrated working group composed of Sferanet resources and specialized physicians from the Policlinico Universitario Campus Bio-Medico Foundation.

The project took second place out of 42 participants in the tender announced by the Lazio Region - Competitive Repositioning CSR - Scope 1 - Life Sciences, and came "to the podium" by obtaining funding from the Region.

The project, writes Olidata, is unique in Italy for both the integrated structured reporting system and the AI system used, a model not present on the ICT market to date. From the first stages of analysis, the accuracy rate in the recognition of nodules is above 90 percent with prospects for growth depending on the massive data analysis capacity that the Olidata software proposes to implement in the next project step, with the aim of speeding up the work of radiology physicians.

The implementation of an Artificial Intelligence system applied to the recognition and classification of pulmonary nodules represents an important starting point for the future use of these technologies in the medical field.

Such a system may have, in fact, a fundamental importance not only for the help it will produce of Radiological Diagnostics, within hospitals, but especially for its use in the field of prevention. International scientific evidence shows, that with screening for the early diagnosis of lung carcinomas rendered by chest CT analysis, a reduction in mortality of between 20 and 26 percent can be achieved.

"For our Group, healthcare is a strategic asset. We know that we can make a great contribution to the development of the healthcare sector by putting technology at the service of hospitals, physicians and professionals, with a positive ultimate impact on patients. We will continue to invest in this sector in the future," says Cristiano Rufini, CEO of Olidata.

Olidata trades in the red by 1.0 percent at EUR0.52 per share.

By Chiara Bruschi, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.